Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Frazer

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Diagnostics (Basel, Switzerland)|March 4, 2017
A Pilot Study into the Association between Oral Health Status and Human Papillomavirus-16 InfectionCharles Xiaohang Sun, Nigel Bennett, Peter Tran, et al.
Vaccine|March 21, 2017
Clinical development strategy for a candidate group A streptococcal vaccineFlorian Schödel, Nicole J Moreland, Janet T Wittes, et al.
Cancers|December 11, 2022
Caerin 1.1/1.9 Enhances Antitumour Immunity by Activating the IFN-α Response Signalling Pathway of Tumour MacrophagesXiaodan Yang, Xiaosong Liu, Junjie Li, et al.
The Journal of Molecular Diagnostics : JMD|July 29, 2021
Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck CancersChameera Ekanayake Weeramange, Zhen Liu, Gunter Hartel, et al.
Cancer Medicine|June 6, 2023
Salivary micro RNAs as biomarkers for oropharyngeal cancerChameera Ekanayake Weeramange, Kai Dun Tang, Roberto A Barrero, et al.
Frontiers in Oncology|July 22, 2024
A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinomaRahul Ladwa, Janin Chandra, Wai-Ping Woo, et al.
International Journal of Cancer|December 4, 2003
Cervical cancer control, priorities and new directionsJoseph Monsonego, F Xavier Bosch, Pierre Coursaget, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2016
Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort StudyZheng Quan Toh, Fiona M Russell, Rita Reyburn, et al.
Science Translational Medicine|September 22, 2021
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchersC Glenn Begley, Mark Ashton, Jonathan Baell, et al.
Gynecologic Oncology|March 17, 2019
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in AustraliaLouiza S Velentzis, Megan A Smith, Kate T Simms, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Diagnostics (Basel, Switzerland)|March 4, 2017
A Pilot Study into the Association between Oral Health Status and Human Papillomavirus-16 InfectionCharles Xiaohang Sun, Nigel Bennett, Peter Tran, et al.
Vaccine|March 21, 2017
Clinical development strategy for a candidate group A streptococcal vaccineFlorian Schödel, Nicole J Moreland, Janet T Wittes, et al.
Cancers|December 11, 2022
Caerin 1.1/1.9 Enhances Antitumour Immunity by Activating the IFN-α Response Signalling Pathway of Tumour MacrophagesXiaodan Yang, Xiaosong Liu, Junjie Li, et al.
The Journal of Molecular Diagnostics : JMD|July 29, 2021
Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck CancersChameera Ekanayake Weeramange, Zhen Liu, Gunter Hartel, et al.
Cancer Medicine|June 6, 2023
Salivary micro RNAs as biomarkers for oropharyngeal cancerChameera Ekanayake Weeramange, Kai Dun Tang, Roberto A Barrero, et al.
Frontiers in Oncology|July 22, 2024
A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinomaRahul Ladwa, Janin Chandra, Wai-Ping Woo, et al.
International Journal of Cancer|December 4, 2003
Cervical cancer control, priorities and new directionsJoseph Monsonego, F Xavier Bosch, Pierre Coursaget, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2016
Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort StudyZheng Quan Toh, Fiona M Russell, Rita Reyburn, et al.
Science Translational Medicine|September 22, 2021
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchersC Glenn Begley, Mark Ashton, Jonathan Baell, et al.
Gynecologic Oncology|March 17, 2019
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in AustraliaLouiza S Velentzis, Megan A Smith, Kate T Simms, et al.
Pageof 3